NEW YORK & TOKYO - Pfizer Inc. (NYSE: NYSE:PFE) and Astellas Pharma Inc. (TSE: TYO:4503) have announced updated results from the Phase 3 EV-302 clinical trial, which showed that the combination of ...

The president has signed an executive order that says the use of the Foreign Corrupt Practices Act has hurt American ...

Emblaveo (aztreonam-avibactam) was approved for treating complicated intra-abdominal infections with limited or no treatment options.

On Friday, the U.S. Judicial Panel on Multidistrict Litigation ordered nearly 70 lawsuits be coordinated beefore U.S.

U.K.-based ad agency DAIVID said Pfizer had a strong, positive message with its ad and scored high with intense positive emotions. The commercial was also a top performer with spikes in positive ...

Investors are undervaluing promising drug candidates on the horizon for the two pharma giants, write Yale SOM’s Jeffrey ...

In a move to position itself as a Pan-African pharmaceutical leader, Neimeth International Pharmaceuticals is targeting the ...

Emblaveo will be available in the third quarter of 2025 to treat patients with intra-abdominal infections, a common cause of sepsis in the intensive care unit.

Pfizer’s contributions to animal health date back several decades, during which the company played a significant role in ...

System1's Test Your Ad data reveals the ads consumers liked best NEW YORK, Feb. 10, 2025 /PRNewswire/ -- System1, The ...